Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Hologic Inc (HOLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 12,639,652
  • Shares Outstanding, K 280,010
  • Annual Sales, $ 2,833 M
  • Annual Income, $ 330,800 K
  • 36-Month Beta 0.91
  • Price/Sales 4.46
  • Price/Cash Flow 12.18
  • Price/Book 4.50

Price Performance

See More
Period Period Low Period High Performance
1-Month
44.13 +0.70%
on 07/11/17
45.97 -3.33%
on 06/28/17
-1.05 (-2.31%)
since 06/27/17
3-Month
42.44 +4.71%
on 05/15/17
46.80 -5.04%
on 06/22/17
-0.14 (-0.31%)
since 04/27/17
52-Week
35.15 +26.43%
on 11/02/16
46.80 -5.04%
on 06/22/17
+7.24 (+19.46%)
since 07/27/16

Most Recent Stories

More News
What's in the Offing for Hologic (HOLX) in Q3 Earnings?

Hologic's (HOLX) gain through product launch and Cynosure integration may get hampered by a dull Cytology performance.

HOLX : 44.44 (-1.55%)
DXTR : 0.25 (unch)
TMO : 175.27 (+0.12%)
IDXX : 164.40 (-1.46%)
TransMed7, LLC Announces Jack Cumming as Director

TransMed7, LLC, today announced the appointment of industry veteran, Jack Cumming as a member of its Board of Directors. Mr. Cumming currently serves as CEO & Managing Director of...

HOLX : 44.44 (-1.55%)
Zacks Industry Outlook Highlights: Teleflex, Medtronic, Johnson & Johnson, Hologic and Wright Medical

Zacks Industry Outlook Highlights: Teleflex, Medtronic, Johnson & Johnson, Hologic and Wright Medical

WMGI : 28.37 (+1.58%)
HOLX : 44.44 (-1.55%)
TFX : 210.42 (-0.76%)
JNJ : 130.83 (-0.09%)
MDT : 84.68 (-1.24%)
MedTech Thriving on Consolidation & Expansion: Stocks to Buy

MedTech Thriving on Consolidation & Expansion: Stocks to Buy

NVRO : 86.57 (-1.47%)
VAR : 100.19 (-2.34%)
BSX : 27.05 (-1.35%)
ABMD : 142.97 (-1.45%)
TFX : 210.42 (-0.76%)
JNJ : 130.83 (-0.09%)
EGRX : 52.94 (-0.81%)
PAHC : 38.45 (-0.39%)
MASI : 95.53 (-1.37%)
GKOS : 41.08 (-3.57%)
OPK : 6.32 (-1.40%)
INGN : 94.27 (-1.48%)
WMGI : 28.37 (+1.58%)
BCR : 321.41 (+0.07%)
HOLX : 44.44 (-1.55%)
EW : 116.36 (+0.65%)
CYH : 7.23 (-14.54%)
ABT : 50.11 (-0.58%)
BDX : 201.67 (-0.52%)
ARAY : 4.40 (-1.12%)
BAX : 60.38 (-1.37%)
MDT : 84.68 (-1.24%)
DXCM : 66.49 (-3.29%)
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2017 on Wednesday, August 2, 2017

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2017 on Wednesday, August 2, 2017, after the market closes. In conjunction...

HOLX : 44.44 (-1.55%)
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert

Hologic, Inc. (Nasdaq: HOLX) announced today that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust Company,...

HOLX : 44.44 (-1.55%)
ENZO BIOCHEM REPORTS DELAWARE COURT RULING

Enzo Biochem Inc. (NYSE: ENZ) reported today that a federal judge for the U.S. District Court for the District of Delaware has entered an order in the actions entitled Enzo Life Sciences, Inc. v. Gen-Probe...

ENZ : 10.97 (-2.83%)
HOLX : 44.44 (-1.55%)
Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe

-- New Panther Fusion((R)) Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory

HOLX : 44.44 (-1.55%)
Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe

Hologic, Inc. (Nasdaq: HOLX) has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory testing, the Company announced today. The Fusion module...

HOLX : 44.44 (-1.55%)
Hologic (HOLX) Product Pipeline Strong, Competition Rife

On Jun 27, we issued an updated research report on Hologic, Inc. (HOLX), headquartered in Bedford, MA.

HOLX : 44.44 (-1.55%)
AXDX : 27.10 (-2.17%)
ALGN : 157.26 (-0.90%)
INGN : 94.27 (-1.48%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Hologic Inc. is a leading supplier of high quality, innovative and clinically valuable diagnostic systems and tests. The company develops, manufactures and markets X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment -- a key...

See More

Support & Resistance

2nd Resistance Point 45.42
1st Resistance Point 45.28
Last Price 44.44
1st Support Level 44.90
2nd Support Level 44.66

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.